Management of PWS is multidisciplinary, with the goal of controlling weight, monitoring and treating comorbid conditions, and replacing hormone deficiencies, including recombinant human growth hormone (rhGH) [1]. This evidence concerns the gene GH1 and Prader-Willi syndrome.